Cruiser Capital Advisors’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Cruiser Capital Advisors’s Portfolio BDMDW Stock Details BDMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.44K	Hold	25,000	–	–	﹤0.01%	48
2025 Q4	$1.35K	Sell	25,000 -2,500	-9%	-$151	﹤0.01%	50
2025 Q3	$1.9K	Hold	27,500	–	–	﹤0.01%	52
2025 Q2	$2.2K	Hold	27,500	–	–	﹤0.01%	44
2025 Q1	$2.06K	Hold	27,500	–	–	﹤0.01%	45
2024 Q4	$5.64K	Buy	+27,500	New	+$1.09K	﹤0.01%	44

Other funds holding BDMDW

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Cruiser Capital Advisors's BDMDW Position: Q1 2026 in Review

Cruiser Capital Advisors held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q1 2026 at 25,000 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #48.

Cruiser Capital Advisors first reported a position in BDMDW in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.64K in Q4 2024. 27 funds tracked by Wall St. Rank hold BDMDW as of Q1 2026.

Cruiser Capital Advisors held 25,000 shares of Baird Medical Investment Holdings Warrant worth $2.44K as of Q1 2026.
Cruiser Capital Advisors left its Baird Medical Investment Holdings Warrant share count unchanged in Q1 2026.
Baird Medical Investment Holdings Warrant made up ﹤0.01% of Cruiser Capital Advisors's portfolio in Q1 2026, its #48 holding.
Cruiser Capital Advisors first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 6 quarters since.
Cruiser Capital Advisors's Baird Medical Investment Holdings Warrant position peaked at $5.64K in Q4 2024.
27 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q1 2026.

Based on Cruiser Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.